Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials to the Overall Type 2 Diabetes Population in the United States
Diabetes, Obesity and Metabolism - United Kingdom
doi 10.1111/dom.13649
Full Text
Open PDFAbstract
Available in full text
Date
March 12, 2019
Authors
Publisher
Wiley